Search

everythinglearnresearchcommunity

for

Search:↓

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

Minoxidil promotes hair growth in women with early-stage alopecia.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Melatonin helps hair growth in women with hair loss.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Finasteride improves hair density and thickness in women with hair loss.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

The dietary supplement helped increase hair growth in women with hair loss.

A scale was made to measure hair loss severity in African American women.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Melatonin improved mental health and metabolism in women with PCOS.

A systematic approach is crucial for managing hair loss in women.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

The nutritional supplement improved hair density and reduced hair loss in women with female pattern hair loss.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

A scarring hair loss condition mainly affects middle-aged women of African descent, impacting their quality of life, with treatments more effective when started early.